Go Pro
NASDAQ:MCTA

Charming Medical (MCTA) Stock Price, News & Analysis

Charming Medical logo
$29.36 0.00 (0.00%)
As of 10/2/2026

About Charming Medical Stock (NASDAQ:MCTA)

Advanced

Key Stats

Today's Range
$29.36
▼
$29.36
50-Day Range
$29.36
▼
$29.36
52-Week Range
$4.30
▼
$31.70
Volume
N/A
Average Volume
N/A
Market Capitalization
$504.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Charming Medical Limited is a medical aesthetics company focused on providing aesthetic medical services. The company operates through its affiliated businesses and serves clients seeking cosmetic and appearance-enhancement treatments.

Its services are understood to include non-surgical medical aesthetics procedures and related cosmetic treatments. Publicly available information about the company’s specific product offerings, operating locations and corporate leadership is limited.

Charming Medical is associated with the medical aesthetics market in China, although detailed information about its geographic footprint and operating structure has not been broadly disclosed. Further company-specific information may become available through its regulatory filings.

AI Generated. May Contain Errors.

Receive MCTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Charming Medical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MCTA Stock News Headlines

Charming Medical Stock Price History
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.tc pixel
See More Headlines

MCTA Stock Analysis - Frequently Asked Questions

Charming Medical's stock was trading at $29.36 on January 28, 2026. Since then, MCTA shares have decreased by 0.0% and is now trading at $29.3550.

Charming Medical (MCTA) raised $8 million in an IPO on Tuesday, October 21st 2025. The company issued 1,600,000 shares at $4.00-$6.00 per share.

Shares of MCTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
10/03/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Diversified Consumer Services
Sub-Industry
Specialized Consumer Services
Current Symbol
NASDAQ:MCTA
CIK
2035992
Fax
N/A
Employees
53
Year Founded
2024

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
17,180,000
Free Float
N/A
Market Cap
$504.32 million
Optionable
N/A
Beta
N/A
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (NASDAQ:MCTA) was last updated on 10/3/2026 by MarketBeat.com Staff.
From Our Partners